Upcoming Events

Previous Day

Wednesday, October 6

Next Day

Biological Engineering Dept. Seminar Series


Biological Engineering is pleased to welcome from Quansys Biosciences - Mr. Adam Brown, CEO; Dr. Brett Baumgartner, R&D; and Mr. Chris Lyman.

Presenting: "Seroprevalence of SARS-CoV-2 studied using a Novel Multiplex ELISA Platform"

A novel multiplex platform for enzyme linked immunoassay (ELISA) has been used to study seroprevalence of antibodies to SARS-CoV-2 in community populations. The assay detects antibodies to Spike 1, Spike 2, and Nucleocapsid epitopes on the SARS-CoV-2 virus. The relative levels of these antibodies, accompanied by a questionnaire, can indicate status of vaccination or prior infection. This platform is being used by University of Minnesota, Minnesota Health Department, and the National Opinion Research Center (NORC) at University of Chicago to examine seroprevalence of antibodies to COVID-19 in Minnesota.

A meet and greet will be immediately following in ENGR 101.

4:30 pm - 5:30 pm | Engineering Building |